The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software

In this episode of The Digital Health Podcast, Lucas and Luna dissect how AliveCor — the small cardiac-diagnostics company that took on Apple over the Apple Watch ECG — won a quiet but significant FDA clearance in April 2026 for its Kardia 12L, a personal 12-lead ECG system that fits in a pocket. They walk through the regulatory strategy, the KardiaMobile 6L’s 2019 clearance as the previous milestone, and why this matters for home-diagnostic access to complex cardiac arrhythmias. They also connect the dots to the broader trend of software-defined medical devices nudging the FDA toward faster pathways for consumer-grade clinical tools. No hype, just the mechanics of how a startup outmanoeuvred the world’s largest company in a regulatory sandbox.

#AliveCor #Kardia12L #Apple #AppleWatch #ECG #12LeadECG #FDA #FDAClearance #CardiacDiagnostics #Wearables #DigitalHealth #RegulatoryStrategy #HomeDiagnostics #MedicalDevice #Business #Technology #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Episode 6 of The Digital Health Podcast zooms in on the Insulet Omnipod 5, the first tubeless automated insulin delivery system. Lucas and Luna break down how this wearable patch pump, paired with a smartphone app and continuous glucose monitor, creates a closed loop that adjusts insulin in real time. They discuss the 2022 FDA approval, the pivotal clinical trial showing a 2.1 percentage point improvement in time-in-range for type 1 diabetes patients, and how the system reduces the mental burden of constant decision-making. The hosts also explore Insulet's market positioning against Medtronic and Tandem Diabetes, the role of Dexcom G6 integration, and why the Omnipod 5 could expand to type 2 diabetes. No jargon overload, just a clear look at how one wearable is changing diabetes management today.

#Insulet #Omnipod5 #ClosedLoop #ArtificialPancreas #Type1Diabetes #CGM #DexcomG6 #WearableTech #DigitalHealth #DiabetesTech #InsulinPump #FDAApproval #TimeInRange #Medtronic #TandemDiabetes #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna dive into the Oura Ring's surprising rise from a niche sleep-tracking gadget to a legitimate research-grade wearable used by the NIH, Stanford, and major pharmaceutical companies. With over 4 million units sold and more than 1,200 peer-reviewed studies citing Oura data, the ring has become a critical tool for remote clinical trials and early disease detection. Lucas explains how Oura's closed-loop hardware-software strategy—unlike Apple or Fitbit—allowed it to prioritize sensor accuracy over consumer features, and why the company's pivot to B2B health partnerships is reshaping the wearable market. The hosts also discuss a landmark 2025 study where Oura rings detected COVID-19 symptoms 48 hours before standard tests, and what that means for the future of continuous health monitoring. No hype, just the numbers and the strategy behind the ring that quietly conquered sleep science.

#OuraRing #WearableTech #SleepResearch #DigitalHealth #ClinicalTrials #NIH #Stanford #HealthTech #RemoteMonitoring #COVID19Detection #SmartRing #HealthData #Biomarkers #MedTech #BusinessStrategy #Science #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Episode 4 of The Digital Health Podcast with Fexingo dives into the looming Medicare telehealth reimbursement cliff set for December 31, 2026. Lucas and Luna unpack the specific flexibilities—like audio-only visits and originating site waivers—that expire, and what that means for virtual care startups. With $250 billion in telehealth claims since 2020 and 40% of Medicare beneficiaries using virtual care in 2025, the stakes are enormous. Lucas walks through the history: the 1135 waiver in March 2020, the Congressional extensions in 2022 and 2024, and the current legislative stalemate. Luna challenges the assumption that in-person care will simply absorb the volume, citing data from the Assistant Secretary for Planning and Evaluation that shows 15% of telehealth visits replace no visit at all. They discuss specific companies like Amwell and Teladoc, whose business models depend on reimbursement parity, and the potential for a targeted extension that preserves audio-only for behavioral health. The conversation is anchored in a concrete date and a clear policy fight, giving listeners one sharp takeaway to track through the summer.

#Telehealth #Medicare #Reimbursement #DigitalHealth #CMS #Policy #VirtualCare #Amwell #Teladoc #BehavioralHealth #HealthcarePolicy #Business #Technology #FexingoBusiness #BusinessPodcast #TheDigitalHealthPodcast #LucasAndLuna #HealthTech

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna examine the FDA's growing backlog of software-as-medical-device submissions, which hit over 1,200 pending applications in early 2026. They trace how the agency's review capacity hasn't kept pace with the explosion of AI diagnostics, digital therapeutics, and remote monitoring tools. The conversation focuses on the specific bottleneck at the 510(k) clearance pathway for SaMD, using the recent case of a cardiac monitoring algorithm that waited 14 months. They explore why some companies are now seeking approval in Europe or Japan first, and what the FDA's new 'Pre-Cert' pilot — currently stalled at 20 participants — could mean for the industry.

#FDA #SaMD #DigitalHealth #SoftwareAsMedicalDevice #510kClearance #AIinHealthcare #DiagnosticAlgorithms #RegulatoryBottleneck #MedicalDeviceRegulation #HealthTech #PreCertProgram #EuropeMDR #RemoteMonitoring #DigitalTherapeutics #CardiacMonitoring #Business #Technology #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

In May 2026, continuous glucose monitors are no longer just for diabetics. Dexcom's over-the-counter CGM, the Stelo, launched last fall and has already enrolled over 400,000 users — a third of whom have no diabetes diagnosis. Lucas and Luna dig into the numbers: how Dexcom priced the device at $89 a month, why the FDA allowed OTC sales for the first time, and what this means for the metabolic health market. They discuss the backlash from endocrinologists who worry about unnecessary medicalization, the early data showing that non-diabetic users change their eating habits after seeing glucose spikes, and the competitive response from Abbott and Apple. If one in three American adults has prediabetes, and CGM data can reduce average blood sugar by 0.8 percent in prediabetic users, is this the biggest untapped market in health tech? A focused episode about one device, one regulatory shift, and the business of knowing your blood sugar.

#Dexcom #Stelo #ContinuousGlucoseMonitor #CGM #DiabetesTech #OverTheCounter #FDA #MetabolicHealth #Prediabetes #GlucoseMonitoring #Abbott #Apple #HealthTech #Wearables #DigitalHealth #Business #BusinessPodcast #FexingoBusiness

Keep every episode free: buymeacoffee.com/fexingo

In the premiere episode of The Digital Health Podcast, hosts Lucas and Luna examine the landmark Apple Heart Study — the largest virtual clinical trial ever conducted, with over 400,000 participants. They break down how the study's one specific finding about atrial fibrillation detection paved the way for a new era in remote diagnostics, and what it means for the future of wearable-driven healthcare. Lucas explains why the study's 0.5 percent positive predictive value was actually a breakthrough, not a failure, and Luna challenges the notion that consumer tech can replace clinical monitoring. The conversation touches on regulatory shifts at the FDA, the economics of health data, and why the next wave of diagnostics might come from your wrist before your doctor's office. This episode sets the stage for a show that will dig into the companies, technologies, and policy decisions shaping digital health — without hype, and with real numbers.

#AppleHeartStudy #Wearables #DigitalHealth #AtrialFibrillation #RemoteMonitoring #ClinicalTrials #WearableDiagnostics #HealthTech #AppleWatch #FDA #MedicalResearch #DigitalTherapeutics #HealthcareInnovation #IrregularRhythm #ConsumerHealth #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo